Breaking News Instant updates and real-time market news.

2019-12-02 08:10:31 PBYI Puma Biotechnology $9.45 0.27 (2.94%) 08:10 12/02/19 12/02 08:10 12/02/19 08:10	Puma Biotechnology amends license agreement with Pierre Fabre Puma Biotechnology and Pierre Fabre have agreed to extend the terms of the license agreement in which Puma granted Pierre Fabre exclusive rights to develop and commercialize NERLYNX within Europe and part of Africa. The amended agreement extends Pierre Fabre's commercial rights for NERLYNX to the Middle East, South Africa, Sudan and Turkey. Under the terms of the agreement, Puma will receive an upfront payment of $4M, as well as additional regulatory and sales-based milestone payments totaling up to $3M. Net sales of NERLYNX from the countries in this extension territory will be included in the calculation of payments related to sales milestones and royalties from the original license agreement signed earlier this year.
PBYI Puma Biotechnology $9.45 0.27 (2.94%) 10/21/19 GSCO 10/21/19 NO CHANGE GSCO Sell Goldman says Seattle Genetics' positive results affirm narrower Puma opportunity Goldman Sachs analyst Paul Choi said Seattle Genetics' (SGEN) positive top-line results from its HER2CLIMB trial of tucatinib in HER2+ breast cancer patients likely affirm a narrower metastatic opportunity for Puma Biotechnology's (PBYI) Nerlynx. Nerlynx will have a first-mover advantage, acknowledges Choi, but he continues to expect low market penetration based on its side effects and lack of an OS benefit, leading him to maintain a Sell rating on Puma shares. 11/07/19 LEHM 11/07/19 NO CHANGE Target $6 LEHM Underweight Puma Biotechnology price target lowered to $6 from $9 at Barclays Barclays analyst Gena Wang lowered her price target for Puma Biotechnology to $6 from $9 and keeps an Underweight rating on the shares. Puma reported Q3 Nerlynx revenue of $53.6M, below the consensus of $59.0M, and lowered its 2019 guidance for the second time to $205M-$210M from $220M-$240M, Wang tells investors in a research note. The analyst continues to see a limited growth outlook in extended adjuvant setting as well as metastatic HER2+ breast cancer. 11/07/19 RBCM 11/07/19 NO CHANGE Target $13 RBCM Sector Perform Puma Biotechnology price target lowered to $13 from $23 at RBC Capital RBC Capital analyst Kennen MacKay lowered his price target on Puma Biotechnology to $13 and kept his Sector Perform rating after its Q3 results showed a miss on Nerlynx sales. The analyst warns that the print may reflect lower demand due to dose-reductions, also noting his lowered estimates in late-stage metastatic breast cancer where he sees greater competitive pressure from other HER2+ agents in that setting. 11/08/19 CANT 11/08/19 NO CHANGE Target $14 CANT Neutral Puma Biotechnology price target lowered to $14 from $20 at Cantor Fitzgerald Cantor Fitzgerald analyst Alethia Young lowered her price target for Puma Biotechnology to $14 from $20 saying she's more cautious on the long-term revenue outlook for Nerlynx following the company's Q3 results. The analyst reiterates a Neutral rating on the shares.

2019-12-02 08:10:31

PBYI

Puma Biotechnology

$9.45: 0.27 (2.94%)

08:10

12/02/19

12/02

08:10

12/02/19

08:10

Puma Biotechnology amends license agreement with Pierre Fabre

Puma Biotechnology and Pierre Fabre have agreed to extend the terms of the license agreement in which Puma granted Pierre Fabre exclusive rights to develop and commercialize NERLYNX within Europe and part of Africa. The amended agreement extends Pierre Fabre's commercial rights for NERLYNX to the Middle East, South Africa, Sudan and Turkey. Under the terms of the agreement, Puma will receive an upfront payment of $4M, as well as additional regulatory and sales-based milestone payments totaling up to $3M. Net sales of NERLYNX from the countries in this extension territory will be included in the calculation of payments related to sales milestones and royalties from the original license agreement signed earlier this year.

PBYI Puma Biotechnology

$9.45: 0.27 (2.94%)

10/21/19: GSCO

11/07/19: LEHM

11/07/19: RBCM

11/08/19: CANT

TODAY'S FREE FLY STORIES

ASMI ASM International $0.00 (0.00%) 06:48 12/12/19 12/12 06:48 12/12/19 06:48 Conference/Events	ASM International management to meet with KeyBanc » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MRK Merck $88.96 -0.12 (-0.13%) 06:47 12/12/19 12/12 06:47 12/12/19 06:47 Hot Stocks	Merck: KEYTRUDA showed improvements in OS in Phase 3 KEYNOTE-042 trial » Merck announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 17 Dec 24 Jan 24 Jan 05 Feb 14 Mar
CG Carlyle Group $30.19 0.69 (2.34%) , APO Apollo Global $44.97 0.67 (1.51%) … 06:47 12/12/19 12/12 06:47 12/12/19 06:47 Downgrade	Carlyle Group, Apollo Global, Ares Management rating change » Carlyle Group downgraded… CG Carlyle Group $30.19 0.69 (2.34%) APO Apollo Global $44.97 0.67 (1.51%) ARES Ares Management $33.56 0.01 (0.03%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb
JCI Johnson Controls $42.71 0.62 (1.47%) 06:47 12/12/19 12/12 06:47 12/12/19 06:47 Initiation	Johnson Controls initiated » Johnson Controls… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
APO Apollo Global $44.97 0.67 (1.51%) 06:46 12/12/19 12/12 06:46 12/12/19 06:46 Downgrade	Apollo Global rating change » Apollo Global downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb

FDX FedEx $159.05 2.07 (1.32%) 06:44 12/12/19 12/12 06:44 12/12/19 06:44 Upgrade	FedEx rating change » FedEx upgraded to Neutral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	17 Dec
IR Ingersoll-Rand $132.95 1.77 (1.35%) 06:42 12/12/19 12/12 06:42 12/12/19 06:42 Initiation	Ingersoll-Rand initiated » Ingersoll-Rand initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ASMB Assembly Biosciences $17.75 0.15 (0.85%) 06:42 12/12/19 12/12 06:42 12/12/19 06:42 Syndicate	Assembly Biosciences 5.152M share Spot Secondary priced at $16.50 » Jefferies and SVB Leerink… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
LL Lumber Liquidators $9.49 -0.04 (-0.42%) 06:41 12/12/19 12/12 06:41 12/12/19 06:41 Earnings	Lumber Liquidators backs FY19 revenue growth view of flat to slightly positive » Consensus $1.09B. Sees… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
IIVI II-VI $30.41 1.05 (3.58%) 06:41 12/12/19 12/12 06:41 12/12/19 06:41 Initiation	II-VI initiated » II-VI initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

LITE Lumentum $69.87 0.97 (1.41%) 06:40 12/12/19 12/12 06:40 12/12/19 06:40 Initiation	Lumentum initiated » Lumentum initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HON Honeywell $176.09 2.1 (1.21%) 06:39 12/12/19 12/12 06:39 12/12/19 06:39 Initiation	Honeywell initiated » Honeywell initiated with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HD Home Depot $211.96 -3.88 (-1.80%) 06:39 12/12/19 12/12 06:39 12/12/19 06:39 Downgrade	Home Depot rating change » With 'mixed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb
ETN Eaton $93.38 0.69 (0.74%) 06:35 12/12/19 12/12 06:35 12/12/19 06:35 Initiation	Eaton initiated » Eaton initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WAL Western Alliance $54.03 -0.15 (-0.28%) 06:35 12/12/19 12/12 06:35 12/12/19 06:35 Conference/Events	Western Alliance management to meet with UBS » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

PLCE Children's Place $54.36 -16.31 (-23.08%) 06:35 12/12/19 12/12 06:35 12/12/19 06:35 Downgrade	Children's Place rating change » Children's Place… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NSC Norfolk Southern $191.07 2.43 (1.29%) 06:34 12/12/19 12/12 06:34 12/12/19 06:34 Conference/Events	Norfolk Southern management to meet with UBS » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
EMR Emerson $75.75 1.21 (1.62%) 06:33 12/12/19 12/12 06:33 12/12/19 06:33 Initiation	Emerson initiated » Emerson initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
VERU Veru $2.47 0.17 (7.39%) 06:33 12/12/19 12/12 06:33 12/12/19 06:33 Earnings	Veru reports Q4 EPS (5c), consensus (5c) » Reports Q4 revenue $8.7M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
TRKNY Turk Telekom $0.00 (0.00%) 06:31 12/12/19 12/12 06:31 12/12/19 06:31 Downgrade	Turk Telekom rating change » Turk Telekom downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AKZOY AkzoNobel $0.00 (0.00%) 06:30 12/12/19 12/12 06:30 12/12/19 06:30 Upgrade	AkzoNobel rating change » AkzoNobel upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CGNX Cognex $52.45 1.51 (2.96%) 06:30 12/12/19 12/12 06:30 12/12/19 06:30 Initiation	Cognex initiated » Cognex initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
COLD Americold Realty Trust $35.03 -0.66 (-1.85%) , INVH Invitation Homes $29.46 -0.42 (-1.41%) 06:29 12/12/19 12/12 06:29 12/12/19 06:29 Recommendations	Americold Realty Trust, Invitation Homes analyst commentary » Citi adds Americold… COLD Americold Realty Trust $35.03 -0.66 (-1.85%) INVH Invitation Homes $29.46 -0.42 (-1.41%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WSG Wanda Sports $2.82 -0.01 (-0.35%) 06:28 12/12/19 12/12 06:28 12/12/19 06:28 Downgrade	Wanda Sports rating change » Wanda Sports downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GKOS Glaukos $57.32 -1.895 (-3.20%) , SPNE SeaSpine $12.00 -0.58 (-4.61%) … 06:27 12/12/19 12/12 06:27 12/12/19 06:27 Downgrade	Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change » SeaSpine, Glaukos… GKOS Glaukos $57.32 -1.895 (-3.20%) SPNE SeaSpine $12.00 -0.58 (-4.61%) MMSI Merit Medical $29.99 0.69 (2.35%) MDT Medtronic $111.67 0.62 (0.56%) TFX Teleflex $354.93 1.18 (0.33%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb

Events

Earnings calls, analyst events, roadshows and more

PT
Today at 07:00

Pintec Technology - PT Conference Calls
VERU
Today at 08:00

Veru - VERU Conference Calls
MET
Today at 08:00

MetLife, Inc. Firm Sponsored Meetings

, New York, NY
Today at 08:30

PPI-FD less food & energy - Y/Y: November 2019 Government Event
Today at 08:30

New Jobless Claims Change: Week 12/7 Government Event
Today at 08:30

PPI-FD less food, energy & trade services - M/M: November 2019 Government Event
Today at 08:30

Jobless Claims--4 Week Moving Average Level: Week 12/7 Government Event
Today at 08:30

PPI-FD less food, energy & trade services - Y/Y: November 2019 Government Event
Today at 08:30

Producer Price Index M/M: November 2019 Government Event
Today at 08:30

6-Month Bill Announcement Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number $12.50-14.50 3.2M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel $18.07 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink $17.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $9.00-10.00 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital $7.51 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James $28.72 6M Shares
Fri	No deals

View All Syndicate Announcements »

Puma Biotechnology amends license agreement with Pierre Fabre

TODAY'S FREE FLY STORIES

Get Full Fly Access